- •Contents
- •Contributors
- •Part I General Principles of Cell Death
- •1 Human Caspases – Apoptosis and Inflammation Signaling Proteases
- •1.1. Apoptosis and limited proteolysis
- •1.2. Caspase evolution
- •2. ACTIVATION MECHANISMS
- •2.2. The activation platforms
- •2.4. Proteolytic maturation
- •3. CASPASE SUBSTRATES
- •4. REGULATION BY NATURAL INHIBITORS
- •REFERENCES
- •2 Inhibitor of Apoptosis Proteins
- •2. CELLULAR FUNCTIONS AND PHENOTYPES OF IAP
- •3. IN VIVO FUNCTIONS OF IAP FAMILY PROTEINS
- •4. SUBCELLULAR LOCATIONS OF IAP
- •8. IAP–IAP INTERACTIONS
- •10. ENDOGENOUS ANTAGONISTS OF IAP
- •11. IAPs AND DISEASE
- •SUGGESTED READINGS
- •1. INTRODUCTION
- •2.1. The CD95 (Fas/APO-1) system
- •2.1.1. CD95 and CD95L: discovery of the first direct apoptosis-inducing receptor-ligand system
- •2.1.2. Biochemistry of CD95 apoptosis signaling
- •2.2. The TRAIL (Apo2L) system
- •3.1. The TNF system
- •3.1.1. Biochemistry of TNF signal transduction
- •3.1.2. TNF and TNF blockers in the clinic
- •3.2. The DR3 system
- •4. THE DR6 SYSTEM
- •6. CONCLUDING REMARKS AND OUTLOOK
- •SUGGESTED READINGS
- •4 Mitochondria and Cell Death
- •1. INTRODUCTION
- •2. MITOCHONDRIAL PHYSIOLOGY
- •3. THE MITOCHONDRIAL PATHWAY OF APOPTOSIS
- •9. CONCLUSIONS
- •SUGGESTED READINGS
- •1. INTRODUCTION
- •3. INHIBITING APOPTOSIS
- •4. INHIBITING THE INHIBITORS
- •6. THE BCL-2 FAMILY AND CANCER
- •SUGGESTED READINGS
- •6 Endoplasmic Reticulum Stress Response in Cell Death and Cell Survival
- •1. INTRODUCTION
- •2. THE ESR IN YEAST
- •3. THE ESR IN MAMMALS
- •4. THE ESR AND CELL DEATH
- •5. THE ESR IN DEVELOPMENT AND TISSUE HOMEOSTASIS
- •6. THE ESR IN HUMAN DISEASE
- •7. CONCLUSION
- •7 Autophagy – The Liaison between the Lysosomal System and Cell Death
- •1. INTRODUCTION
- •2. AUTOPHAGY
- •2.2. Physiologic functions of autophagy
- •2.3. Autophagy and human pathology
- •3. AUTOPHAGY AND CELL DEATH
- •3.1. Autophagy as anti–cell death mechanism
- •3.2. Autophagy as a cell death mechanism
- •3.3. Molecular players of the autophagy–cell death cross-talk
- •4. AUTOPHAGY, CELLULAR DEATH, AND CANCER
- •5. CONCLUDING REMARKS AND PENDING QUESTIONS
- •SUGGESTED READINGS
- •8 Cell Death in Response to Genotoxic Stress and DNA Damage
- •1. TYPES OF DNA DAMAGE AND REPAIR SYSTEMS
- •2. DNA DAMAGE RESPONSE
- •2.2. Transducers
- •2.3. Effectors
- •4. CHROMATIN MODIFICATIONS
- •5. CELL CYCLE CHECKPOINT REGULATION
- •6. WHEN REPAIR FAILS: SENESCENCE VERSUS APOPTOSIS
- •6.1. DNA damage response and the induction of apoptosis
- •6.2. p53-independent mechanisms of apoptosis
- •6.3. DNA damage response and senescence induction
- •7. DNA DAMAGE FROM OXIDATIVE STRESS
- •SUGGESTED READINGS
- •9 Ceramide and Lipid Mediators in Apoptosis
- •1. INTRODUCTION
- •3.1. Basic cell signaling often involves small molecules
- •3.2. Sphingolipids are cell-signaling molecules
- •3.2.1. Ceramide induces apoptosis
- •3.2.2. Ceramide accumulates during programmed cell death
- •3.2.3. Inhibition of ceramide production alters cell death signaling
- •4.1. Ceramide is generated through SM hydrolysis
- •4.3. aSMase can be activated independently of extracellular receptors to regulate apoptosis
- •4.4. Controversial aspects of the role of aSMase in apoptosis
- •4.5. De novo ceramide synthesis regulates programmed cell death
- •4.6. p53 and Bcl-2–like proteins are connected to de novo ceramide synthesis
- •4.7. The role and regulation of de novo synthesis in ceramide-mediated cell death is poorly understood
- •5. CONCLUDING REMARKS AND FUTURE DIRECTIONS
- •5.1. Who? (Which enzyme?)
- •5.2. What? (Which ceramide?)
- •5.3. Where? (Which compartment?)
- •5.4. When? (At what steps?)
- •5.5. How? (Through what mechanisms?)
- •5.6. What purpose?
- •6. SUMMARY
- •SUGGESTED READINGS
- •1. General Introduction
- •1.1. Cytotoxic lymphocytes and apoptosis
- •2. CYTOTOXIC GRANULES AND GRANULE EXOCYTOSIS
- •2.1. Synthesis and loading of the cytotoxic granule proteins into the secretory granules
- •2.2. The immunological synapse
- •2.3. Secretion of granule proteins
- •2.4. Uptake of proapoptotic proteins into the target cell
- •2.5. Activation of death pathways by granzymes
- •3. GRANULE-BOUND CYTOTOXIC PROTEINS
- •3.1. Perforin
- •3.2. Granulysin
- •3.3. Granzymes
- •3.3.1. GrB-mediated apoptosis
- •3.3.2. GrA-mediated cell death
- •3.3.3. Orphan granzyme-mediated cell death
- •5. CONCLUSIONS
- •REFERENCES
- •Part II Cell Death in Tissues and Organs
- •1.1. Death by trophic factor deprivation
- •1.2. Key molecules regulating neuronal apoptosis during development
- •1.2.1. Roles of caspases and Apaf-1 in neuronal cell death
- •1.2.2. Role of Bcl-2 family members in neuronal cell death
- •1.3. Signal transduction from neurotrophins and neurotrophin receptors
- •1.3.1. Signals for survival
- •1.3.2. Signals for death
- •2.1. Apoptosis in neurodegenerative diseases
- •2.1.4. Amyotrophic lateral sclerosis
- •2.2. Necrotic cell death in neurodegenerative diseases
- •2.2.1. Calpains
- •2.2.2. Cathepsins
- •3. CONCLUSIONS
- •ACKNOWLEDGMENT
- •SUGGESTED READINGS
- •ACKNOWLEDGMENT
- •SUGGESTED READINGS
- •1. INTRODUCTION
- •5. S-NITROSYLATION OF PARKIN
- •7. POTENTIAL TREATMENT OF EXCESSIVE NMDA-INDUCED Ca2+ INFLUX AND FREE RADICAL GENERATION
- •8. FUTURE THERAPEUTICS: NITROMEMANTINES
- •9. CONCLUSIONS
- •Acknowledgments
- •SUGGESTED READINGS
- •3. MITOCHONDRIAL PERMEABILITY TRANSITION ACTIVATED BY Ca2+ AND OXIDATIVE STRESS
- •4.1. Mitochondrial apoptotic pathways
- •4.2. Bcl-2 family proteins
- •4.3. Caspase-dependent apoptosis
- •4.4. Caspase-independent apoptosis
- •4.5. Calpains in ischemic neural cell death
- •5. SUMMARY
- •ACKNOWLEDGMENTS
- •SUGGESTED READINGS
- •1. INTRODUCTION
- •2. HISTORICAL ANTECEDENTS
- •7.1. Activation of p21 waf1/cip1: Targeting extrinsic and intrinsic pathways to death
- •8. CONCLUSION
- •ACKNOWLEDGMENTS
- •REFERENCES
- •16 Apoptosis and Homeostasis in the Eye
- •1.1. Lens
- •1.2. Retina
- •2. ROLE OF APOPTOSIS IN DISEASES OF THE EYE
- •2.1. Glaucoma
- •2.2. Age-related macular degeneration
- •4. APOPTOSIS AND OCULAR IMMUNE PRIVILEGE
- •5. CONCLUSIONS
- •SUGGESTED READINGS
- •17 Cell Death in the Inner Ear
- •3. THE COCHLEA IS THE HEARING ORGAN
- •3.1. Ototoxic hair cell death
- •3.2. Aminoglycoside-induced hair cell death
- •3.3. Cisplatin-induced hair cell death
- •3.4. Therapeutic strategies to prevent hair cell death
- •3.5. Challenges to studies of hair cell death
- •4. SPIRAL GANGLION NEURON DEATH
- •4.1. Neurotrophic support from sensory hair cells and supporting cells
- •4.2. Afferent activity from hair cells
- •4.3. Molecular manifestations of spiral ganglion neuron death
- •4.4. Therapeutic interventions to prevent SGN death
- •ACKNOWLEDGMENTS
- •SUGGESTED READINGS
- •18 Cell Death in the Olfactory System
- •1. Introduction
- •2. Anatomical Aspects
- •3. Life and Death in the Olfactory System
- •3.1. Olfactory epithelium
- •3.2. Olfactory bulb
- •REFERENCES
- •1. Introduction
- •3.1. Beta cell death in the development of T1D
- •3.2. Mechanisms of beta cell death in type 1 diabetes
- •3.2.1. Apoptosis signaling pathways downstream of death receptors and inflammatory cytokines
- •3.2.2. Oxidative stress
- •3.3. Mechanisms of beta cell death in type 2 diabetes
- •3.3.1. Glucolipitoxicity
- •3.3.2. Endoplasmic reticulum stress
- •5. SUMMARY
- •Acknowledgments
- •REFERENCES
- •20 Apoptosis in the Physiology and Diseases of the Respiratory Tract
- •1. APOPTOSIS IN LUNG DEVELOPMENT
- •2. APOPTOSIS IN LUNG PATHOPHYSIOLOGY
- •2.1. Apoptosis in pulmonary inflammation
- •2.2. Apoptosis in acute lung injury
- •2.3. Apoptosis in chronic obstructive pulmonary disease
- •2.4. Apoptosis in interstitial lung diseases
- •2.5. Apoptosis in pulmonary arterial hypertension
- •2.6. Apoptosis in lung cancer
- •SUGGESTED READINGS
- •21 Regulation of Cell Death in the Gastrointestinal Tract
- •1. INTRODUCTION
- •2. ESOPHAGUS
- •3. STOMACH
- •4. SMALL AND LARGE INTESTINE
- •5. LIVER
- •6. PANCREAS
- •7. SUMMARY AND CONCLUDING REMARKS
- •SUGGESTED READINGS
- •22 Apoptosis in the Kidney
- •1. NORMAL KIDNEY STRUCTURE AND FUNCTION
- •3. APOPTOSIS IN ADULT KIDNEY DISEASE
- •4. REGULATION OF APOPTOSIS IN KIDNEY CELLS
- •4.1. Survival factors
- •4.2. Lethal factors
- •4.2.1. TNF superfamily cytokines
- •4.2.2. Other cytokines
- •4.2.3. Glucose
- •4.2.4. Drugs and xenobiotics
- •4.2.5. Ischemia-reperfusion and sepsis
- •5. THERAPEUTIC APPROACHES
- •SUGGESTED READINGS
- •1. INTRODUCTION
- •2. APOPTOSIS IN THE NORMAL BREAST
- •2.1. Occurrence and role of apoptosis in the developing breast
- •2.2.2. Death ligands and death receptor pathway
- •2.2.4. LIF-STAT3 proapoptotic signaling
- •2.2.5. IGF survival signaling
- •2.2.6. Regulation by adhesion
- •2.2.7. PI3K/AKT pathway: molecular hub for survival signals
- •2.2.8. Downstream regulators of apoptosis: the BCL-2 family members
- •3. APOPTOSIS IN BREAST CANCER
- •3.1. Apoptosis in breast tumorigenesis and cancer progression
- •3.2. Molecular dysregulation of apoptosis in breast cancer
- •3.2.1. Altered expression of death ligands and their receptors in breast cancer
- •3.2.2. Deregulation of prosurvival growth factors and their receptors
- •3.2.3. Alterations in cell adhesion and resistance to anoikis
- •3.2.4. Enhanced activation of the PI3K/AKT pathway in breast cancer
- •3.2.5. p53 inactivation in breast cancer
- •3.2.6. Altered expression of BCL-2 family of proteins in breast cancer
- •5. CONCLUSION
- •SUGGESTED READINGS
- •1. INTRODUCTION
- •2. DETECTING CELL DEATH IN THE FEMALE GONADS
- •4. APOPTOSIS AND FEMALE REPRODUCTIVE AGING
- •6. CONCLUDING REMARKS
- •REFERENCES
- •25 Apoptotic Signaling in Male Germ Cells
- •1. INTRODUCTION
- •3.1. Murine models
- •3.2. Primate models
- •3.3. Pathways of caspase activation and apoptosis
- •3.4. Apoptotic signaling in male germ cells
- •5. P38 MITOGEN-ACTIVATED PROTEIN KINASE (MAPK) AND NITRIC OXIDE (NO)–MEDIATED INTRINSIC PATHWAY SIGNALING CONSTITUTES A CRITICAL COMPONENT OF APOPTOTIC SIGNALING IN MALE GERM CELLS AFTER HORMONE DEPRIVATION
- •11. CONCLUSIONS AND PERSPECTIVES
- •REFERENCES
- •26 Cell Death in the Cardiovascular System
- •1. INTRODUCTION
- •2. CELL DEATH IN THE VASCULATURE
- •2.1. Apoptosis in the developing blood vessels
- •2.2. Apoptosis in atherosclerosis
- •2.2.1. Vascular smooth muscle cells
- •2.2.2. Macrophages
- •2.2.3. Regulation of apoptosis in atherosclerosis
- •2.2.4. Necrosis and autophagy in atherosclerosis
- •3. CELL DEATH IN THE MYOCARDIUM
- •3.1. Cell death in myocardial infarction
- •3.1.1. Apoptosis in myocardial infarction
- •3.1.2. Necrosis in myocardial infarction
- •3.1.3. Autophagy in myocardial infarction
- •3.2. Cell death in heart failure
- •3.2.1. Apoptosis in heart failure
- •3.2.2. Necrosis in heart failure
- •3.2.3. Autophagy in heart failure
- •4. CONCLUDING REMARKS
- •ACKNOWLEDGMENTS
- •REFERENCES
- •27 Cell Death Regulation in Muscle
- •1. INTRODUCTION TO MUSCLE
- •1.1. Skeletal muscle adaptation to endurance training
- •1.2. Myonuclear domains
- •2. MITOCHONDRIALLY MEDIATED APOPTOSIS IN MUSCLE
- •2.1. Skeletal muscle apoptotic susceptibility
- •4. APOPTOSIS IN MUSCLE DURING AGING AND DISEASE
- •4.1. Aging
- •4.2. Type 2 diabetes mellitus
- •4.3. Cancer cachexia
- •4.4. Chronic heart failure
- •6. CONCLUSION
- •SUGGESTED READINGS
- •28 Cell Death in the Skin
- •1. INTRODUCTION
- •2. CELL DEATH IN SKIN HOMEOSTASIS
- •2.1. Cornification and apoptosis
- •2.2. Death receptors in the skin
- •3. CELL DEATH IN SKIN PATHOLOGY
- •3.1. Sunburn
- •3.2. Skin cancer
- •3.3. Necrolysis
- •3.4. Pemphigus
- •3.5. Eczema
- •3.6. Graft-versus-host disease
- •4. CONCLUDING REMARKS AND PERSPECTIVES
- •ACKNOWLEDGMENTS
- •SUGGESTED READINGS
- •29 Apoptosis and Cell Survival in the Immune System
- •2.1. Survival of early hematopoietic progenitors
- •2.2. Sizing of the T-cell population
- •2.2.1. Establishing central tolerance
- •2.2.2. Peripheral tolerance
- •2.2.3. Memory T cells
- •2.3. Control of apoptosis in B-cell development
- •2.3.1. Early B-cell development
- •2.3.2. Deletion of autoreactive B cells
- •2.3.3. Survival and death of activated B cells
- •3. IMPAIRED APOPTOSIS AND LEUKEMOGENESIS
- •4. CONCLUSIONS
- •ACKNOWLEDGMENTS
- •REFERENCES
- •30 Cell Death Regulation in the Hematopoietic System
- •1. INTRODUCTION
- •2. HEMATOPOIETIC STEM CELLS
- •4. ERYTHROPOIESIS
- •5. MEGAKARYOPOIESIS
- •6. GRANULOPOIESIS
- •7. MONOPOIESIS
- •8. CONCLUSION
- •ACKNOWLEDGMENTS
- •REFERENCES
- •31 Apoptotic Cell Death in Sepsis
- •1. INTRODUCTION
- •2. HOST INFLAMMATORY RESPONSE TO SEPSIS
- •3. CLINICAL OBSERVATIONS OF CELL DEATH IN SEPSIS
- •3.1. Sepsis-induced apoptosis
- •3.2. Necrotic cell death in sepsis
- •4.1. Central role of apoptosis in sepsis mortality: immune effector cells and gut epithelium
- •4.2. Apoptotic pathways in sepsis-induced immune cell death
- •4.3. Investigations implicating the extrinsic apoptotic pathway in sepsis
- •4.4. Investigations implicating the intrinsic apoptotic pathway in sepsis
- •5. THE EFFECT OF APOPTOSIS ON THE IMMUNE SYSTEM
- •5.1. Cellular effects of an increased apoptotic burdens
- •5.2. Network effects of selective loss of immune cell types
- •5.3. Studies of immunomodulation by apoptotic cells in other fields
- •7. CONCLUSION
- •REFERENCES
- •32 Host–Pathogen Interactions
- •1. INTRODUCTION
- •2. FROM THE PATHOGEN PERSPECTIVE
- •2.1. Commensals versus pathogens
- •2.2. Pathogen strategies to infect the host
- •3. HOST DEFENSE
- •3.1. Antimicrobial peptides
- •3.2. PRRs and inflammation
- •3.2.1. TLRs
- •3.2.2. NLRs
- •3.2.3. The Nod signalosome
- •3.2.4. The inflammasome
- •3.3. Cell death
- •3.3.1. Apoptosis and pathogen clearance
- •3.3.2. Pyroptosis
- •3.2.3. Caspase-independent cell death
- •3.2.4. Autophagy and autophagic cell death
- •4. CONCLUSIONS
- •REFERENCES
- •Part III Cell Death in Nonmammalian Organisms
- •1. PHENOTYPE AND ASSAYS OF YEAST APOPTOSIS
- •2.1. Pheromone-induced cell death
- •2.1.1. Colony growth
- •2.1.2. Killer-induced cell death
- •3. EXTERNAL STIMULI THAT INDUCE APOPTOSIS IN YEAST
- •4. THE GENETICS OF YEAST APOPTOSIS
- •5. PROGRAMMED AND ALTRUISTIC AGING
- •SUGGESTED READINGS
- •34 Caenorhabditis elegans and Apoptosis
- •1. Overview
- •2. KILLING
- •3. SPECIFICATION
- •4. EXECUTION
- •4.1. DNA degradation
- •4.2. Mitochondrial elimination
- •4.3. Engulfment
- •5. SUMMARY
- •SUGGESTED READINGS
- •35 Apoptotic Cell Death in Drosophila
- •2. DROSOPHILA CASPASES AND PROXIMAL REGULATORS
- •6. CLOSING COMMENTS
- •SUGGESTED READINGS
- •36 Analysis of Cell Death in Zebrafish
- •1. INTRODUCTION
- •2. WHY USE ZEBRAFISH TO STUDY CELL DEATH?
- •2.2. Molecular techniques to rapidly assess gene function in embryos
- •2.2.1. Studies of gene function using microinjections into early embryos
- •2.2.2. In situ hybridization and immunohistochemistry
- •2.3. Forward genetic screening
- •2.4. Drug and small-molecule screening
- •2.5. Transgenesis
- •2.6. Targeted knockouts
- •3.1. Intrinsic apoptosis
- •3.2. Extrinsic apoptosis
- •3.3. Chk-1 suppressed apoptosis
- •3.4. Anoikis
- •3.5. Autophagy
- •3.6. Necrosis
- •4. DEVELOPMENTAL CELL DEATH IN ZEBRAFISH EMBRYOS
- •5. THE P53 PATHWAY
- •6. PERSPECTIVES AND FUTURE DIRECTIONS
- •SUGGESTED READING
26 Cell Death in the Cardiovascular System
Vladimir Kaplinskiy, Martin R. Bennett, and Richard N. Kitsis
1. INTRODUCTION
Cardiovascular disease is the most common cause of death in the world. Regulated forms of cell death play critical roles in cardiovascular disease. In particular, apoptosis and necrosis, and perhaps autophagic cell death, are causal components in the pathogenesis of the most common and lethal cardiovascular syndromes: myocardial infarction and heart failure. This chapter summarizes the mechanisms and physiologic impact of regulated cell death in the cardiovascular system.
2. CELL DEATH IN THE VASCULATURE
2.1. Apoptosis in the developing blood vessels
Vascular development requires not only the formation, but also the regression, of blood vessels. For example, components of the first, second, and fifth aortic arches involute during embryonic development. Similarly, the ductus arteriosus, which shunts blood past the lungs in fetal life, becomes a fibrotic vestigial structure after the initiation of postnatal pulmonary function. Changes of this sort are accompanied by apoptosis of endothelial and smooth muscle cells,1,2,3,4 suggesting that cell death is involved in vascular regression and remodeling.
A causal connection between cell death and vascular remodeling has been demonstrated by genetic manipulations in the mouse. For example, loss of survival pathways can cause marked reductions in blood vessel abundance. This is illustrated by endothelial cellspecific deletion of IKKβ (IκB [inhibitor of κB] kinase β), which results in caspase activation, marked reductions in liver blood vessels, and lethality at embryonic days 13.5 through 15.5.5 Similarly, knockout of Bcl-2 (B- cell leukemia/lymphoma-2) results in apoptosis, reduc-
tion in the abundance of endothelial cells and pericytes, and decreased retinal artery density in postnatal mice.6 Conversely, loss of apoptosis signaling can lead to extra vessels. This is illustrated by combined knockouts of Bax (Bcl-2–associated X protein) and Bak (Bcl-2 homologous antagonist/killer), which display loss of normally occurring endothelial cell apoptosis with persistence of fetal retinal vessels.7
A variety of physiologic stimuli, including shear stress, interactions with extracellular matrix, and soluble factors, such as vascular endothelial growth factor, promote endothelial cell survival.8 Conversely, endothelial cells in regressing capillary beds can be killed by Wnts secreted from macrophages.9 Moreover, reductions in capillary flow resulting from the killed endothelial cells can then reduce shear stress and delivery of nutrients, thereby leading to further endothelial cell death.10,11
In contrast, the role of apoptosis in the remodeling of larger vessels is not known. For example, reduction of carotid blood flow in adult rabbits and mice stimulates endothelial cell and/or smooth muscle cell apoptosis. The vascular lumen becomes smaller, but this may be due to reactive smooth muscle cell proliferation, matrix deposition, and overall vessel shrinkage. Moreover, apoptosis of vascular cells in arteries may cause only variable and, in some cases, transient vascular changes.12,13 For these reasons, the significance of flow-mediated cell death in the remodeling of large vessels remains unclear.
2.2. Apoptosis in atherosclerosis
The advanced human atherosclerotic plaque is formed through a complex series of events that involve all arterial cell types (Figure 26-1), as follows: (1) Endothelial cell dysfunction/damage is an initiating event. (2) This
295
296 |
VLADIMIR KAPLINSKIY, MARTIN R. BENNETT, AND RICHARD N. KITSIS |
Tunica adventitia connective tissue
Tunica intima
endothelium
internal elastic lamina
external elastic lamina
smooth muscle cells
Tunica media
Figure 26-1. Normal human artery consists of three layers. The tunica intima (intima), the layer closest to the lumen of the vessel through which blood flows, is composed of a single layer of endothelial cells resting on a basement membrane. The tunica media (media) is comprised of multiple layers of vascular smooth muscle cells. The tunica adventitia (adventitia), the outermost layer, is composed of fibroblasts and collagen-rich matrix containing nerves, lymphatics, and small blood vessels. Internal and external elastic laminae separate intima from media and media from adventitia, respectively. Reprinted with permission from School of Anatomy and Human Biology – The University of Western Australia. See Color Plate 28.
Levels of apoptosis are low to undetectable in the normal vessel wall18 but increase progressively during plaque development.18,19,20,21 This cell death occurs in both the necrotic core and the fibrous cap. Most apoptosis in plaques involves vascular smooth muscle cells and macrophages. We focus first on smooth muscle cell death.
2.2.1. Vascular smooth muscle cells
Transgenic mice that express diphtheria toxin receptor exclusively in arterial smooth muscle cells have been used to investigate a causal connection between smooth muscle cell apoptosis and atherogenesis (Figure 26-3a). These studies show that modestly elevated levels of vascular smooth muscle cell apoptosis (0.8%– 1.1%) – comparable to those seen in human plaques – are sufficient to accelerate plaque progression in an atherogenic milieu (apolipoprotein E−/– [apoe−/–] mice on a high-fat diet).22 The underlying mechanisms are incompletely understood but involve proinflammatory effects of apoptotic cells.23
Studies have also linked vascular smooth muscle cell apoptosis with plaque rupture (Figure 26-3b). Increased levels of vascular smooth muscle cell apoptosis are associated with rupture-prone coronary artery plaques24,25 in patients with unstable angina as compared with those with stable angina.26 The most direct evidence, however,
leads to recruitment of monocytes/macrophages into the intima. (3) Uptake of lipids into the macrophages results in their transformation to foam cells. (4) Foam and endothelial cells signal the migration of vascular smooth muscle cells from media to intima, where their replication and collagen/matrix production form a fibrous cap. This fibrous cap separates the thrombogenic, lipid-rich “necrotic core” of the plaque from the flowing blood.14,15 Myocardial infarction (“heart attack,” discussed later in this chapter), is the acute death of heart muscle cells resulting from the sudden cessation of blood flow in a coronary artery. Rather than being precipitated by progressive arterial narrowing, most myocardial infarctions are triggered by acute rupture of the fibrous cap of the plaque (Figure 26-2).16,17 Contact between thrombogenic factors in the plaque and the flowing blood then activates platelets, leading to subsequent thrombosis and coronary artery occlusion.
Atherosclerosis
Plaque Instability
Myocardial Infarction
Heart Failure
Figure 26-2. Relationship between atherosclerosis, myocardial infarction, and heart failure. Rupture of an atherosclerotic plaque acutely precipitates myocardial infarction. Myocardial infarction can lead to heart failure. See text for details.
CELL DEATH IN THE CARDIOVASCULAR SYSTEM |
297 |
a |
Control Apoe-/- |
SM22α-hDTR Apoe-/- |
b |
Control Apoe-/- |
SM22α-hDTR Apoe-/- |
Figure 26-3. Vascular smooth muscle cell apoptosis accelerates atherosclerotic plaque progression22 and induces plaque vulnerability.27 Transgenic mice were created in which expression of the human diphtheria toxin receptor was targeted to arterial smooth muscle cells. Animals were crossed onto an apoe−/– background and fed a highfat diet to induce atherosclerosis. Apoptosis of arterial smooth muscle cells was induced by administration of diphtheria toxin. This model was used to study the e ects of arterial smooth muscle cell apoptosis on plaque progression and instability. Apoptosis accelerated plaque formation in the brachiocephalic artery as shown by increased plaque area by hematoxylin and eosin staining (a). Plaque vulnerability was increased by apoptosis (not shown) in the carotid artery, as illustrated by thinning of the fibrous cap, loss of collagen and matrix, increased necrotic core size, cellular debris, and inflammation (Masson trichrome staining in b and not shown). Space bars 100 μM (a) and 50 μM (b). (a) Reproduced with permission from Clarke MC, Littlewood TD, Figg N, Maguire JJ, Davenport AP, Goddard M, Bennett MR. Chronic apoptosis of vascular smooth muscle cells accelerates atherosclerosis and promotes calcification and medial degeneration. Circ Res. 2008;102:1529– 38. (b) Reprinted by permission from Macmillan Publishers Ltd: Clark MC, Figg N, Maguire JJ, Davenport AP, Goddard M, Littlewood TD, Bennett MR. Apoptosis of vascular smooth muscle cells induces features of plaque vulnerability in atherosclerosis. Nat Med. 2006;12:1075–80. See Color Plate 29.
is provided by the diphtheria toxin receptor transgenic mouse, described in the previous paragraph. Induction of vascular smooth muscle cell apoptosis results in thinning of the fibrous cap, loss of collagen and matrix, accumulation of lipids and cellular debris within an increased necrotic core, and formation of inflammatory foci within the atherosclerotic lesion.27 Although thinning of the fibrous cap does not progress to overt rupture in this model, these data suggest that vascular smooth muscle cell apoptosis can precipitate features of plaque instability in an atherosclerotic context. Although these studies demonstrate the sufficiency of vascular smooth muscle cell apoptosis for plaque instability, the necessity of cell death in this process remains to be evaluated.
2.2.2. Macrophages
Macrophages are the most frequent apoptotic cell type in advanced lesions.18 Apoptosis of these cells may have varying effects on atherosclerosis at different times in the disease process. During atherogenesis, macrophage apoptosis appears to reduce lesion formation. Consistent with this, diphtheria toxin-mediated killing of macrophages in apoe−/– mice fed a high-fat diet results in reduced plaque and necrotic core size.28 Conversely, adoptive transfer of bax−/– bone marrow into mice lacking the low-density-lipoprotein receptor and on a highfat diet showed increased plaque area compared with mice reconstituted with wild-type cells.29 These studies suggest that macrophage apoptosis limits plaque development. In contrast, macrophage apoptosis in established plaques may increase the necrotic core size without affecting plaque size.30
A related theory is that changes in clearance of apoptotic bodies promote progression of established plaque. Inhibition of phagocytosis, through loss-of- function mutations in Mertk (MER tyrosine kinase) or lactadherin, accelerates atherosclerosis in established plaques and is accompanied by increases in necrotic core size.31,32,33 In fact, the efficiency of phagocytosis appears decreased in the milieu of atherosclerotic plaques.34 The precise relationship between apoptosis and phagocytosis with regard to atherogenesis remains to be delineated.
Endoplasmic reticulum (ER) stress has also been implicated in the role of macrophages in atherosclerosis. ER stress may be stimulated by lipid-mediated oxidative damage and/or increased accumulation of free cholesterol within macrophages.35, 36 Markers of the unfolded protein response (UPR) are activated during all phases of plaque development.37 Deletion of CHOP [C/EBP (CCAAT/enhancer binding protein)-homologous protein], which transcriptionally activates genes that mediate both UPR and ER stress-induced apoptosis, lowers rates of macrophage apoptosis and reduces necrotic core size in atherosclerosis-prone mice.38 Furthermore, CHOP and GRP78 (glucose-regulated protein 78, another UPR marker), are increased in ruptured, but not stable, human plaques. These observations suggest a role for ER stress in necrotic core formation and human plaque rupture.39
2.2.3. Regulation of apoptosis in atherosclerosis
Resident vessel wall cells are resistant to apoptosis induced by death ligands, in part because of increased levels of FLIP [FLICE (FADD-Like IL-1β-converting